Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of GDC-0449 in advanced chondrosarcomas
2010-019817-20Phase 2Completed
- Sponsor
- Institut Bergonié
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of vismodegib in chondrosarcoma, sponsored by Institut Bergonié. Primary endpoint: 6-month clinical benefit rate. Started Oct 2010; status: completed.
02
Drugs
vismodegib
03
Conditions
chondrosarcoma
Beyond the preview
Go deeper on 2010-019817-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019817-20.